Gulia Abhishek, Anand Anil Kumar, Punnakal Anirudh Urumi, Kumar Amit, Patro Ch Kartikeswar, Bansal Anil Kumar
Department of Radiation Oncology, Max Super Speciality Hospital, Saket, India.
Department of Radio-diagnosis, Max Super Speciality Hospital, Saket, India.
BJR Case Rep. 2018 Mar 14;4(3):20160114. doi: 10.1259/bjrcr.20160114. eCollection 2018 Mar.
We describe a case of non-seminomatous germ cell tumour (NSGCT) of the testis with oligorecurrence in para-aortic nodal mass, which was inoperable and chemorefractory. Conventionally fractionated radiotherapy in this setting is generally believed to achieve poor results, because the dose is limited by the tolerance of surrounding normal tissues. Use of stereotactic ablative body radiotherapy (SABR) for para-aortic nodal recurrence from a few sites has been reported; its application in NSGCT has not been described in literature to our knowledge. SABR allowed us to deliver highly precise, ablative dose of radiation to the recurrent para-aortic nodal mass with long-term disease control (more than 6 years). The ablative dose delivered with SABR proved to be effective in NSGCT, traditionally considered radioresistant. While, in the present case SABR was delivered due to the inoperability of the lesion, further data on its successful use in NSGCT recurrences is warranted.
我们描述了一例睾丸非精原细胞瘤(NSGCT)伴腹主动脉旁淋巴结肿块寡转移的病例,该肿块无法手术且对化疗耐药。在这种情况下,传统分割放疗通常被认为效果不佳,因为剂量受到周围正常组织耐受性的限制。已有报道称立体定向消融体部放疗(SABR)可用于治疗少数部位的腹主动脉旁淋巴结复发;据我们所知,其在NSGCT中的应用尚未见文献描述。SABR使我们能够向复发的腹主动脉旁淋巴结肿块精确地给予消融剂量的辐射,并实现长期疾病控制(超过6年)。SABR给予的消融剂量在传统上被认为对放疗耐药的NSGCT中被证明是有效的。虽然在本病例中,由于病变无法手术而采用了SABR,但仍需要进一步关于其在NSGCT复发中成功应用的数据。